Abstract | OBJECTIVES: The present study was undertaken to standardize skin testing and to develop a safe and effective premedication protocol for administration of ERIG in those with skin test positivity/ hypersensitivity. METHODS: RESULTS: The premedication protocol was safe and effective as all the S1 subjects could be administered the full dose of ERIG despite being skin test positive/hypersensitive to ERIG. Besides the premedication drugs/protocol did not affect the immune response to vaccine and ERIG therapy.
|
Authors | M K Sudarshan, N S Kodandaram, G M Venkatesh, B J Mahendra, D H Ashwath Narayana, B G Parasuramalu |
Journal | Indian journal of public health
(Indian J Public Health)
2007 Apr-Jun
Vol. 51
Issue 2
Pg. 91-6
ISSN: 0019-557X [Print] India |
PMID | 18240468
(Publication Type: Journal Article)
|
Chemical References |
- Glucocorticoids
- Histamine H1 Antagonists
- Immunoglobulins
- Rabies Vaccines
- Ranitidine
|
Topics |
- Adolescent
- Adult
- Aged
- Animals
- Child
- Child, Preschool
- Clinical Protocols
- Drug Hypersensitivity
(complications, prevention & control)
- Female
- Glucocorticoids
(therapeutic use)
- Histamine H1 Antagonists
(therapeutic use)
- Horses
- Humans
- Immunoglobulins
(administration & dosage)
- Infant
- Infant, Newborn
- Intradermal Tests
- Male
- Middle Aged
- Premedication
- Rabies
(complications, prevention & control)
- Rabies Vaccines
(administration & dosage)
- Ranitidine
(therapeutic use)
|